Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pediatric Study Incentive Could Be Tax Credit, Not Exclusivity - Rep. Pallone

This article was originally published in The Tan Sheet

Executive Summary

Tax credits or reimbursements may be alternative incentives to encourage manufacturers to conduct pediatric studies, Rep. Frank Pallone (D-N.J.) suggested during a House Energy & Commerce/Health Subcommittee hearing May 3.

You may also be interested in...



House Commerce Health Subcommittee Generics Hearing Planned For June

The House Energy & Commerce Committee/Health Subcommittee intends to hold a hearing on generic drug issues in June.

PDUFA III Could Move Through Congress In 2001, Rep. Burr Suggests

FDA's post-approval surveillance system should be discussed as part of the reauthorization process for the Prescription Drug User Fee Act, Rep. Richard Burr (R-N.C.) said during a May 3 House Energy & Commerce Committee/Health Subcommittee hearing on implementation of the FDA Modernization Act.

House Commerce Health Subcommittee Generics Hearing Planned For June

The House Energy & Commerce Committee/Health Subcommittee intends to hold a hearing on generic drug issues in June.

Related Content

Topics

UsernamePublicRestriction

Register

OM013658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel